Ligand validation:7XR9

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7XR9_NAD_B_401	65%	3%	0.158	0.959	3.78	2.3	17	9	6	0	100%	1
7XR9_NAD_C_402	58%	3%	0.161	0.939	3.92	2.34	21	14	7	0	100%	1
7XR9_NAD_E_402	48%	2%	0.183	0.928	4.04	2.44	22	16	6	0	100%	1
7XR9_NAD_F_402	47%	3%	0.177	0.917	3.84	2.3	18	9	11	0	100%	1
7XR9_NAD_D_402	37%	62%	0.186	0.883	0.69	0.76	1	2	7	0	100%	1
7XR9_NAD_A_402	27%	16%	0.189	0.836	2.16	1.57	17	7	7	0	100%	1
7XRE_NAD_B_401	76%	2%	0.091	0.927	4.14	2.46	18	12	6	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
2BJK_NAD_A_1517	100%	59%	0.025	0.995	0.72	0.86	-	1	1	0	100%	0.86
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.